Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes Registry.

Ohkuma T, Fujii H, Iwase M, Ogata-Kaizu S, Ide H, Kikuchi Y, Idewaki Y, Jodai T, Hirakawa Y, Nakamura U, Kitazono T.

Metabolism. 2014 Apr;63(4):484-91. doi: 10.1016/j.metabol.2013.12.001. Epub 2013 Dec 7.

PMID:
24411997
2.

Association between sleep duration and urinary albumin excretion in patients with type 2 diabetes: the Fukuoka diabetes registry.

Ohkuma T, Fujii H, Iwase M, Ogata-Kaizu S, Ide H, Kikuchi Y, Idewaki Y, Jodai T, Hirakawa Y, Nakamura U, Kitazono T.

PLoS One. 2013 Nov 12;8(11):e78968. doi: 10.1371/journal.pone.0078968. eCollection 2013.

3.

Impact of dietary fiber intake on glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.

Fujii H, Iwase M, Ohkuma T, Ogata-Kaizu S, Ide H, Kikuchi Y, Idewaki Y, Joudai T, Hirakawa Y, Uchida K, Sasaki S, Nakamura U, Kitazono T.

Nutr J. 2013 Dec 11;12:159. doi: 10.1186/1475-2891-12-159.

4.
5.

Impact of leisure-time physical activity on glycemic control and cardiovascular risk factors in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.

Kaizu S, Kishimoto H, Iwase M, Fujii H, Ohkuma T, Ide H, Jodai T, Kikuchi Y, Idewaki Y, Hirakawa Y, Nakamura U, Kitazono T.

PLoS One. 2014 Jun 4;9(6):e98768. doi: 10.1371/journal.pone.0098768. eCollection 2014.

6.

Dose- and time-dependent association of smoking and its cessation with glycemic control and insulin resistance in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.

Ohkuma T, Iwase M, Fujii H, Kaizu S, Ide H, Jodai T, Kikuchi Y, Idewaki Y, Hirakawa Y, Nakamura U, Kitazono T.

PLoS One. 2015 Mar 30;10(3):e0122023. doi: 10.1371/journal.pone.0122023. eCollection 2015.

7.

Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry.

Ohkuma T, Fujii H, Iwase M, Kikuchi Y, Ogata S, Idewaki Y, Ide H, Doi Y, Hirakawa Y, Nakamura U, Kitazono T.

Diabetes Care. 2013 Mar;36(3):611-7. doi: 10.2337/dc12-0904. Epub 2012 Nov 12.

8.

Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.

Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.

Diabetes Care. 2007 May;30(5):1219-25. Epub 2007 Jan 26.

PMID:
17259468
9.

High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome.

Rosolova H, Petrlova B, Simon J, Sifalda P, Sipova I.

Med Sci Monit. 2008 Aug;14(8):CR411-5.

PMID:
18667998
10.

Relation between metabolic syndrome and sleep duration in Japan: a large scale cross-sectional study.

Kobayashi D, Takahashi O, Deshpande GA, Shimbo T, Fukui T.

Intern Med. 2011;50(2):103-7. Epub 2011 Jan 15.

11.

Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.

Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G.

Metabolism. 2006 Apr;55(4):445-52.

PMID:
16546474
12.

The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M.

Diabet Med. 2004 Jan;21(1):52-8.

PMID:
14706054
13.

Epidemiology of the metabolic syndrome, 2002.

Meigs JB.

Am J Manag Care. 2002 Sep;8(11 Suppl):S283-92; quiz S293-6. Review.

14.

Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes.

De Cosmo S, Lamacchia O, Rauseo A, Viti R, Gesualdo L, Pilotti A, Trischitta V, Cignarelli M.

Diabetes Care. 2006 Nov;29(11):2467-70.

PMID:
17065686
16.

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.

Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G, Keech AC; FIELD Study Investigators.

Cardiovasc Diabetol. 2011 Nov 21;10:102. doi: 10.1186/1475-2840-10-102.

17.

The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.

Kendall DM, Harmel AP.

Am J Manag Care. 2002 Dec;8(20 Suppl):S635-53; quiz S654-7. Review.

18.

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

Wannamethee SG, Shaper AG, Lennon L, Whincup PH.

Diabetes Care. 2005 Dec;28(12):2913-8.

PMID:
16306554
19.

Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance.

Hermans MP, Ahn SA, Mahadeb YP, Rousseau MF.

Diabetes Metab Res Rev. 2013 Mar;29(3):227-34. doi: 10.1002/dmrr.2387.

PMID:
23283827
20.

Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.

Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW.

Diabetes. 2005 Nov;54(11):3252-7.

Supplemental Content

Support Center